San Diego, CA, United States of America

Donmienne Doen Mun Leung

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2010-2025

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovative Work of Inventor Donmienne Doen Mun Leung

Introduction:

Inventor Donmienne Doen Mun Leung from San Diego, CA, has made significant contributions to the field of medicine with his groundbreaking inventions. With a total of 11 patents to his name, Leung's work is focused on developing compounds and antibodies for the treatment of various diseases, including cancer and proliferative retinopathies.

Latest Patents:

Leung's latest patents include:

1. VEGFA/Ang2 Compounds: These compounds target human Vascular Endothelial Growth Factor A (VEGFA) and human Angiopoietin-2 (Ang2), with potential applications in treating angiogenic eye diseases and solid tumors like gastric, lung, and breast cancers.

2. Ang2 Antibodies: These antibodies bind to human Angiopoietin-2 (Ang2) and show promise in treating cancer, particularly in combination with VEGF pathway inhibitors for cancers driven by VEGFR2 and Ang2.

Career Highlights:

Currently affiliated with Eli Lilly and Company, Leung continues to drive innovation in the pharmaceutical industry. His work at Eli Lilly has been instrumental in developing novel therapeutics for challenging medical conditions.

Collaborations:

Leung collaborates closely with esteemed colleagues such as Ying Tang and Derrick Ryan Witcher. Together, they combine their expertise to pioneer new treatment options and improve patient outcomes in the healthcare sector.

Conclusion:

In conclusion, Inventor Donmienne Doen Mun Leung's inventive spirit and dedication to advancing medical science through his patented compounds and antibodies are commendable. His work not only benefits patients with various diseases but also inspires further research and innovation in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…